Experimental therapy crosses blood-brain barrier to treat neurological disease

Experimental therapy crosses blood-brain barrier to treat neurological disease

 

 Experimental therapy crosses blood-brain barrier to treat neurological disease. Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy […]

Continue reading »
ApoE Is an ideal target for halting progression of Alzheimer’s disease

ApoE Is an ideal target for halting progression of Alzheimer’s disease

 

  ApoE Is an ideal target for halting progression of Alzheimer’s disease. Despite researchers’ best efforts, no drug exists that can slow, halt or reverse […]

Continue reading »